Femasys Inc. (FEMY )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol FEMY
- Company Femasys Inc.
- Price $3.2
- Changes Percentage 14.7
- Change 0.41
- Day Low $2.76
- Day High $3.35
- Year High $22.2
- Year Low $2.02
- Market Cap $8,937,821
- Price Avg 50 EMA (D) $3.38
- Price Avg 200 EMA (D) $9.48
- Exchange NASDAQ
- Volume 567,496
- Average Volume 721,095
- Open $2.81
- Previous Close $2.79
- EPS -4.49
- PE -0.66
- Earnings Announcement 2026-11-17 12:00:00
- Shares Outstanding $3,019,534
Company brief: FEMASYS INC. (FEMY )
- Healthcare
- Medical - Instruments & Supplies
- Ms. Kathy Lee-Sepsick M.B.A.
- https://www.femasys.com
- US
- N/A
- 06-18-2021
- US31447E1055
Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.